Tiba Biotech LLC
Cambridge, MA
- UEI
- XNL9ZSLHN795
- CAGE
- 7QLV7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1 Broadway fl 14, Cambridge, MA 02142, USA
- Website
- tiba.bio
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Tiba Biotech LLC
Tiba Biotech LLC is a Cambridge, Massachusetts-based for-profit limited liability company specializing in innovative RNA vaccine technologies and delivery platforms. The company develops advanced RNA-based therapeutic and vaccine solutions, focusing on creating rapid-response platforms for addressing various infectious diseases and medical challenges. Its core expertise lies in developing cutting-edge RNA delivery systems, particularly utilizing proprietary dendrimer-based nanoparticle technologies that maximize RNA mass content, protect nucleic acids from degradation, and enable efficient cellular uptake.
Through its federal contract work, Tiba Biotech LLC has secured a significant $749,999.01 firm-fixed-price contract with the U.S. Department of Health and Human Services, specifically the Office of the Assistant Secretary for Preparedness and Response. This contract focuses on research and development of a respiratory virus treatment using lung-targeted small interfering RNA (siRNA) delivery. The contract, which does not have a set-aside designation, is scheduled for completion by October 31, 2025. Additionally, the company has served as a subcontractor for the Icahn School of Medicine at Mount Sinai, providing RNA vaccines to support studies on influenza immunity and protection.
Tiba Biotech LLC has been awarded multiple federal grants from agencies like the National Cancer Institute and the National Institute of Allergy and Infectious Diseases, supporting advanced research in RNA-based vaccine technologies. These grants include developing a cancer immunotherapy approach using enhanced self-amplifying RNA (esRNA) with spleen-targeting delivery nanomaterials, creating a high-potency, low-dose Powassan virus RNA vaccine, and designing multi-antigen RNA vaccines for pandemic influenza and SARS-CoV-2. The grant projects demonstrate the company's capabilities in developing innovative vaccine platforms that can rapidly respond to emerging infectious disease threats, with a particular focus on creating more effective, efficiently manufactured vaccine candidates using proprietary dendrimer-based delivery systems and replicon RNA technologies.
Quick answers
What is Tiba Biotech LLC's UEI?
Tiba Biotech LLC's Unique Entity ID (UEI) in SAM.gov is XNL9ZSLHN795.
What is Tiba Biotech LLC's CAGE code?
Tiba Biotech LLC's CAGE code is 7QLV7.
What is Tiba Biotech LLC's primary NAICS code?
Tiba Biotech LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Tiba Biotech LLC located?
Tiba Biotech LLC's physical address in SAM.gov is 1 Broadway fl 14, Cambridge, MA 02142, USA.
Is Tiba Biotech LLC registered in SAM.gov?
Yes. Tiba Biotech LLC's SAM.gov registration is active through January 27, 2027.
What is Tiba Biotech LLC's most recent federal award?
Tiba Biotech LLC's most recent federal grant award is Lung-targeting delivery of small interfering RNA for pulmonary therapeutics - nucleic acid-based interventions have… (R43HL184887), from National Heart Lung and Blood Institute, on August 1, 2026.
On GovTribe
See Tiba Biotech LLC's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors